Global $23.9 Billion Antibody Drug Conjugate Markets to 2028: Major Players are Entering into Partnerships for Development & Commercialization
September 16, 2021 04:38 ET
|
Research and Markets
Dublin, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugate Market" report has been added to ResearchAndMarkets.com's offering. The global antibody drug conjugate market size is...
Tasrif Pharmaceutical Announces Grant of U.S. Patent for Humanized Monoclonal Antibodies against the Poliovirus Receptor
August 25, 2021 12:00 ET
|
Tasrif Pharmaceutical, LLC
BOSTON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Tasrif Pharmaceutical announces the grant of a US Patent related to its proprietary humanized monoclonal antibodies against the poliovirus receptor (a.k.a....
Antibody Drug Conjugates Market CAGR predicted at 15.4% by 2031: Visiongain Research Inc.
July 08, 2021 10:31 ET
|
Visiongain Ltd
Visiongain has published a new report on Global Antibody Drug Conjugates Market Report Forecast 2021-2031. Forecasts : By Technology (Cleavable Linkers, Non-Cleavable Linkers, Other Technology), By...
Global $10 Billion Bi-Specific MAbS Markets, 2015-2020, 2020-2025F, 2030F
June 23, 2021 05:48 ET
|
Research and Markets
Dublin, June 23, 2021 (GLOBE NEWSWIRE) -- The "Bi-Specific MAbS Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global...
Global Antibody Partnering Deals, Terms and Agreements Report 2021
June 11, 2021 05:38 ET
|
Research and Markets
Dublin, June 11, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Partnering Terms and Agreements 2014-2021" report has been added to ResearchAndMarkets.com's offering. The Global Antibody Partnering...
Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
April 09, 2021 16:00 ET
|
Genmab A/S
Company Announcement FDA action date is Oct 10, 2021BLA submission supported by positive pivotal innovaTV 204 trial results presented at the European Society of Medical Oncology Virtual Congress...
Global Bi-Specific MAbS Market Report 2020: Market is Expected to Stabilize and Reach $6.12 Billion by 2023 - Long-term Forecast to 2025 & 2030
March 25, 2021 06:43 ET
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Bi-Specific MAbS Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Bi-Specific...
Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
February 10, 2021 16:05 ET
|
Genmab A/S
Company Announcement Submission based on positive pivotal innovaTV 204 trial results presented at the European Society of Medical Oncology Virtual Congress 2020 COPENHAGEN, Denmark and BOTHELL,...
Global Antibody Partnering Terms and Agreements Directory 2020: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target
February 05, 2021 06:53 ET
|
Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Antibody Partnering Terms and Agreements 2014-2020" report has been added to ResearchAndMarkets.com's offering. The Global Antibody Partnering...
Growing at an annualized rate of over 12%, the ADC contract manufacturing market is estimated to reach close to USD 3 Billion by 2030, claims Roots Analysis
February 04, 2021 11:00 ET
|
Roots Analysis
London, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “ADC Contract Manufacturing Market (4th Edition), 2020-2030” report to its list of offerings. Manufacturing of...